Sweden· SE-19960621000019
Caelyx pegylated liposomal 2 mg/ml Koncentrat till infusionsvätska, lösning
A medicinal product containing doxorubicin hydrochloride, registered in Sweden by Baxter Holding B.V..
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Doxorubicin Hydrochloride
- Manufacturer
- Baxter Holding B.V.
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19960621000019
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Doxorubicin hydrochloride in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumCaelyx Pegylated Liposomal 2 mg/mlBaxter Holding
- CzechiaCAELYX PEGYLATED LIPOSOMALBaxter Holding B.V., Utrecht
- FinlandCaelyx Pegylated LiposomalOrifarm Oy
- IrelandCaelyx pegylated liposomal 2 mg/ml concentrate for solution for infusionBaxter Holding B.V.
- PolandCaelyx pegylated liposomalBaxter Holding B.V.
- NorwayCaelyx pegylated liposomalBaxter Holding B.V.
- IcelandCaelyx pegylated liposomalBaxter Holding B.V.*
- United StatesDOXILBaxter Healthcare Corporation
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Adriblastin, Doxorubicin Accord
- Belgium · Adriblastina Ready To Use, Doxorubicin Accord Healthcare
- Bulgaria · Доксорубицин Акорд
- Cyprus · Adriblastina
- Czechia · Doxorubicin Ebewe, Doxorubicin Medac
- Germany · Adriacept Blasen-Instillations-Set, Adrimedac
- Denmark · Adriamycin, Doxorubicin Accord
- Estonia · Doxorubicin Accord
- Spain · Doxorubicina Accord, Doxorubicina Aurovitas
- Finland · Doxorubicin Accord, Doxorubicin Medac
- France · Adriblastine, Doxorubicin Teva
- United Kingdom (Northern Ireland) · Doxorubicin Accord Healthcare, Doxorubicin Hydrochloride Medac
- Greece · Adriblastina, Doxiprol
- Croatia · Doxorubicin Pliva, Sindroxocin
- Hungary · Doxorubicin Accord, Doxorubicin Sandoz
- Ireland · Doxorubicin Accord Healthcare Ireland, Doxorubicin Rivopharm
- Iceland · Caelyx Pegylated Liposomal, Doxorubicin Medac
- Italy · Adriblastina, Doxorubicin Teva
- Liechtenstein · Caelyx Pegylated Liposomal, Myocet Liposomal
- Lithuania · Doxorubicin Accord, Doxorubicin Ebewe
- Luxembourg · Adriblastina Ready To Use, Doxorubicine Teva
- Latvia · Doxorubicin Accord
- Malta · Doxorubicin Accord Healthcare
- Netherlands · Doxorubicin Hydrochloride Eugia, Doxorubicine Accord
- Norway · Adriamycin, Caelyx Pegylated Liposomal
- Poland · Doxorubicin Ebewe, Doxorubicinum Accord
- Portugal · Doxorrubicina Accord, Doxorrubicina Aurovitas
- Romania · Doxlox, Doxorubicină Accord
- Slovenia · Doksorubicin Accord, Doksorubicin Sandoz
- Slovakia · Doxorubicin Medac, Doxorubicin Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7019c74d-0424-4e58-8e45-245a4eb9e882 GET /v1/drugs/7019c74d-0424-4e58-8e45-245a4eb9e882?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"Dispensbeslut",
"EMA"
],
"se_npl_id": "19960621000019",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19960621000019",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/caelyx-epar-product-information_sv.pdf"
}See everything about doxorubicin hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.